The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: Factom Inc.

9 Jul 2020 07:00

RNS Number : 4644S
FastForward Innovations Limited
09 July 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

9 July 2020

 

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

 

Investee Company Update: FastForward Innovations response to Factom Inc. filing for Chapter 11 reorganisation

 

FastForward Innovations Ltd announces that further to its announcement on 22 June 2020 confirming that investee company Factom, Inc. ("Factom") has initiated a bankruptcy proceeding in the United States Bankruptcy Court for the District of Delaware (the "Delaware Court") seeking reorganisation under Chapter 11 of the US Bankruptcy Code, FastForward has filed its appearance in Factom's bankruptcy case, and also motions requesting that the Delaware Court: (i) dismiss Factom's bankruptcy case so that a receiver may be appointed to liquidate Factom's assets in a Texas state court; (ii) alternatively, to convert Factom's bankruptcy case to a liquidation proceeding under Chapter 7 of the US Bankruptcy Code, or (ii) alternatively, to transfer Factom's bankruptcy case from the Delaware Court to the US Bankruptcy Court for the Western District of Texas, Austin Division (the "Texas Court"). With these filings, FastForward also responds to certain statements made in the proposed plan of reorganisation filed by Factom.

 

Factom's proposed plan of reorganisation includes an application for the discharge of various debts of Factom, including an application for the Court to set aside the obligations of Factom under FastFoward's $6 million SAFE note. The board of FastForward strongly opposes the proposed reorganisation of Factom on the terms proposed in Factom's proposed plan of reorganisation, and rejects claims made by Factom that FastForward is acting as a barrier to Factom raising capital. If Factom's case is not dismissed or converted, then FastForward will oppose the confirmation of any plan that would seek to discharge the SAFE note, whether in the Delaware Court or the Texas Court.

 

FastForward is represented in Factom's bankruptcy case by Seth Meisel of DuBois, Bryant & Campbell in Austin, Texas, and Daniel Astin of Ciardi, Ciardi & Astin, LLP in Wilmington, Delaware.

 

The Board of FastForward reserves its position in respect of any future legal action and will make further announcements as the court proceedings in the US progress and/ or new claims or and/ or new filings are submitted by Factom and/ or the Company.

 

The Company's interest in Factom is divided between Series Seed shares and the SAFE which were valued at £581,000 and £4,880,000 respectively as at 30 September 2019 but were subsequently written down to zero as announced on 14 April 2020 (to be reported at the next Balance Sheet date being 31 March 2020).

 

About FastForward Innovations Limited

FastForward innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

Cautionary Statement

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

 

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

*** ENDS***

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

 

Graham Dickson

Optiva Securities Limited,

Broker

 

Tel: +44 (0) 203 411 1881

 

Beth Melluish / Susie Geliher

St Brides Partners Ltd,

Financial PR

 

Tel: +44 (0)207 236 1177

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDGGDRCUGDGGI
Date   Source Headline
6th Apr 20167:00 amRNSInvestee Company Update
5th Apr 20162:50 pmRNSInvestee Company Update
4th Apr 20167:00 amRNSInvestee Company Update: Schoold
31st Mar 20161:18 pmRNSInvestee Company Update
9th Mar 201610:00 amRNSExpected announcement date of 2016 Final Results
4th Mar 201610:01 amRNSInvestee Company Update
3rd Mar 20165:15 pmRNSInvestee Company Update: Vemo
19th Feb 20167:00 amRNSGrant of Options
18th Feb 20168:21 amRNSHolding(s) in Company
15th Feb 20165:23 pmRNSTransaction in Own Shares
15th Feb 20161:26 pmRNSFurther Investment in Yooya
12th Feb 20165:19 pmRNSCompletion Placing
8th Feb 20166:20 pmRNSPlacing Update
2nd Feb 20167:00 amRNSInvestee Company Update
28th Jan 20167:00 amRNSPlacing
27th Jan 20164:47 pmRNSLorne Abony Appointed as Chief Executive Officer
26th Jan 20167:00 amRNSInvestment
11th Jan 20164:27 pmRNSHolding(s) in Company
11th Jan 201612:33 pmRNSInvestment in Yooya Media
6th Jan 20161:47 pmRNSDirectorate Change
5th Jan 20165:19 pmRNSCompletion of investment in VEMO and Placing
29th Dec 20157:00 amRNSNew Website
22nd Dec 20153:08 pmRNSPlacing and Director Dealing
21st Dec 20155:56 pmRNSAcquisition of shares in Vemo Education, Inc
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
17th Dec 20157:00 amRNSInvestee Company Update - Vemo Education Inc
2nd Dec 20154:26 pmRNSHolding(s) in Company
26th Nov 201511:02 amRNSPlacing
25th Nov 20157:00 amRNSInvestee Company Update - Vemo Education Inc
23rd Nov 20156:05 pmRNSHolding(s) in Company
23rd Nov 201511:36 amRNSResult of General Meeting
23rd Nov 20157:00 amRNSAcquisition
13th Nov 20157:00 amRNSHalf Yearly Report
10th Nov 20151:32 pmRNSPlacing
3rd Nov 20157:00 amRNSProposed Name Change
29th Oct 20157:00 amRNSCorporate Update
22nd Oct 20153:35 pmRNSInvestee company Intensity Therapeutics update
14th Oct 20157:53 amRNSInvestment in Factom
6th Oct 20158:03 amRNSInvestment in Intensity Therapeutics Inc
21st Sep 20157:00 amRNS10% Acquired of nanopayment developer SatoshiPay
18th Sep 201510:32 amRNSResult of AGM
8th Sep 20157:00 amRNSIssue of Equity
7th Sep 20157:00 amRNSAcquisition
1st Sep 20157:03 amRNSIssue of Equity
31st Jul 20158:24 amRNSUpdate on Investment review
28th Jul 201511:36 amRNSResult of EGM
13th Jul 20158:00 amRNSChange of Investing Policy and Name
13th Jul 20157:00 amRNSDirectorate Change
23rd Jun 20152:36 pmRNSNotice of AGM
17th Jun 20159:34 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.